Validation of HB-EGF and amphiregulin as targets for human cancer therapy.
暂无分享,去创建一个
Satoshi O. Suzuki | E. Oki | S. Miyamoto | H. Yagi | Fusanori Yotsumoto | T. Kawarabayashi | E. Mekada | K. Sonoda | H. Tsujioka | Touru Hachisuga
[1] R. Singal,et al. EGFR targeting of solid tumors. , 2007, Cancer control : journal of the Moffitt Cancer Center.
[2] C. Der,et al. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer , 2007, Oncogene.
[3] Hiroshi Suzuki,et al. Expression of amphiregulin during the pre- and post-implantation period in the mouse reproductive tract. , 2006, Journal of reproduction and development.
[4] A. Citri,et al. EGF–ERBB signalling: towards the systems level , 2006, Nature Reviews Molecular Cell Biology.
[5] R. Wanke,et al. Betacellulin overexpression in transgenic mice causes disproportionate growth, pulmonary hemorrhage syndrome, and complex eye pathology. , 2005, Endocrinology.
[6] Ho-Yyoung Lee,et al. Resistance to epidermal growth factor receptor-targeted therapy. , 2005, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[7] Satoshi O. Suzuki,et al. Clinical Significance of Heparin-Binding Epidermal Growth Factor–Like Growth Factor and A Disintegrin and Metalloprotease 17 Expression in Human Ovarian Cancer , 2005, Clinical Cancer Research.
[8] E. Mekada,et al. Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing , 2005, Journal of Cell Science.
[9] David C. Lee,et al. Novel Role for Amphiregulin in Protection from Liver Injury* , 2005, Journal of Biological Chemistry.
[10] H. Lane,et al. ERBB receptors and cancer: the complexity of targeted inhibitors , 2005, Nature Reviews Cancer.
[11] S. Miyamoto,et al. Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer , 2005, British Journal of Cancer.
[12] J. Baselga,et al. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] David C. Lee,et al. Heparin-binding Epidermal Growth Factor-like Growth Factor Links Hepatocyte Priming with Cell Cycle Progression during Liver Regeneration* , 2005, Journal of Biological Chemistry.
[14] V. Godfrey,et al. Epiregulin Is Not Essential for Development of Intestinal Tumors but Is Required for Protection from Intestinal Damage , 2004, Molecular and Cellular Biology.
[15] M. Kai,et al. Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy , 2004, Cancer Research.
[16] S. Chan,et al. Epidermal Growth Factor as a Biologic Switch in Hair Growth Cycle* , 2003, Journal of Biological Chemistry.
[17] David C. Lee,et al. Defective valvulogenesis in HB‐EGF and TACE‐null mice is associated with aberrant BMP signaling , 2003, The EMBO journal.
[18] Robert J Coffey,et al. EGF receptor ligands. , 2003, Experimental cell research.
[19] Masatsugu Hori,et al. Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] E. Coene,et al. The role of heregulin‐α as a motility factor and amphiregulin as a growth factor in wound healing , 2002, The Journal of pathology.
[21] S. Leach,et al. Transgenic overexpression of amphiregulin induces a mitogenic response selectively in pancreatic duct cells. , 2002, Gastroenterology.
[22] David C. Lee,et al. Growth retardation, duodenal lesions, and aberrant ileum architecture in triple null mice lacking EGF, amphiregulin, and TGF-alpha. , 2001, Gastroenterology.
[23] A. Schulze,et al. Analysis of the transcriptional program induced by Raf in epithelial cells , 2001, Nature Genetics.
[24] Fiona M. Watt,et al. The EGF Receptor Provides an Essential Survival Signal for SOS-Dependent Skin Tumor Development , 2000, Cell.
[25] David C. Lee,et al. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. , 1999, Development.
[26] D. Stern,et al. Specificity within the EGF family/ErbB receptor family signaling network , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.
[27] S. Oldham,et al. A Raf-independent Epidermal Growth Factor Receptor Autocrine Loop Is Necessary for Ras Transformation of Rat Intestinal Epithelial Cells* , 1997, The Journal of Biological Chemistry.
[28] J. Abraham,et al. Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. , 1995, Genes & development.
[29] N. Normanno,et al. Epidermal growth factor-related peptides and their receptors in human malignancies. , 1995, Critical reviews in oncology/hematology.
[30] M. Klagsbrun,et al. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor , 1995, The Journal of cell biology.
[31] R. Coffey,et al. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. , 1995, Gastroenterology.
[32] E. Nice,et al. Mice with a null mutation of the TGFα gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation , 1993, Cell.
[33] David C. Lee,et al. TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice , 1993, Cell.
[34] T. Uchida,et al. Diphtheria toxin and related proteins. I. Isolation and properties of mutant proteins serologically related to diphtheria toxin. , 1973, The Journal of biological chemistry.